249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. (Q54654711)

2 June 2018

title

249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. (English)

1 reference

2 June 2018

1 reference

7

Pierre Hainaut

1 reference

2 June 2018

1

Gregory D Kirk

1 reference

2 June 2018

James J Goedert

6

object named as

James J Goedert

1 reference

2 June 2018

Ruggero Montesano

8

object named as

Ruggero Montesano

1 reference

2 June 2018

Hilton C. Whittle

5

object named as

Hilton Whittle

1 reference

2 June 2018

author name string

Olufunmilayo A Lesi

2

1 reference

2 June 2018

Maimuna Mendy

3

1 reference

2 June 2018

Katarzyna Szymañska

4

1 reference

2 June 2018

language of work or name

English

0 references

publication date

1 September 2005

1 reference

2 June 2018

published in

Oncogene

1 reference

2 June 2018

volume

24

1 reference

2 June 2018

page(s)

5858-5867

1 reference

2 June 2018

issue

38

1 reference

2 June 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208732

exact match

0 references

cites work

Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Cancer in the Gambia: 1988-97.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Aflatoxins isolated by immunoaffinity chromatography from foods consumed in The Gambia, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

P53 gene mutations: case study of a clinical marker for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Hepatocellular carcinoma: from gene to public health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Peanut butter intake, GSTM1 genotype and hepatocellular carcinoma: a case-control study in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

p53 mutation in hepatocellular carcinoma after aflatoxin exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

The dynamics of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Hepatitis B infection and aflatoxin biomarker levels in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Risk factors for transmission of hepatitis B virus to Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Molecular pathogenesis of human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Aflatoxin-albumin adducts in human sera from different regions of the world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Aflatoxin detected in human breast milk by immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Field studies of aflatoxin exposure, metabolism and induction of genetic alterations in relation to HBV infection and hepatocellular carcinoma in The Gambia and Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Environmental and genetic determinants of aflatoxin-albumin adducts in the Gambia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Impacts of chemicals on liver cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Kinetic Instability of p53 Core Domain Mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

Geographic variation of p53 mutational profile in nonmalignant human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

7 January 2021

The mouse equivalent of the human p53ser249 mutation p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic and p53 heterozygous null mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

7 January 2021

Hepatitis B e Antigen--the dangerous endgame of hepatitis B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

7 January 2021

Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

7 January 2021

The pattern of childhood hepatitis B infection in two Gambian villages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208732

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208732

1 reference

2 June 2018

PubMed ID

16007211

1 reference

2 June 2018